A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 5,018,178 shares of IKNA stock, worth $8.53 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
5,018,178
Previous 5,018,178 -0.0%
Holding current value
$8.53 Million
Previous $7.13 Million 16.2%
% of portfolio
1.1%
Previous 0.89%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

May 16, 2022

BUY
$10.52 - $16.96 $52.8 Million - $85.1 Million
5,018,178 New
5,018,178 $62.9 Million

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $61.6M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.